Fujifilm Holdings Corp. said the company is seeking to have the flu drug Avigan approved in Japan as a treatment for Covid-19, a move that comes after a late-stage study showed reduced recovery times for patients with non-severe symptoms.

Fujifilm Holdings Corp. said a late-stage study of Avigan showed the antiviral drug reduced recovery times for Covid-19 patients with non-severe symptoms, boosting expectations for regulatory approval in Japan.